Reversal of small, dense LDL subclass phenotype by normalization of adiposity
- PMID: 19498345
- PMCID: PMC2837149
- DOI: 10.1038/oby.2009.146
Reversal of small, dense LDL subclass phenotype by normalization of adiposity
Abstract
Excess adiposity and high-carbohydrate diets have been associated with an atherogenic lipoprotein phenotype (ALP) characterized by increased concentrations of small, dense low-density lipoprotein (LDL) particles (pattern B). We tested whether weight loss and normalization of adiposity could reverse ALP in overweight men with pattern B. After consuming a moderate-carbohydrate, high-fat diet for 3 weeks, pattern B and nonpattern B (pattern A) men were randomized to a weight loss (n = 60 and n = 36, respectively) or control weight-stable arm (n = 20 and n = 17, respectively). Men in the weight loss arm consumed approximately 1,000 fewer calories per day over 9 weeks to induce an average approximately 9 kg weight loss. In the control group, weight stability was maintained for 4 weeks after randomization. Weight loss led to the conversion of pattern B to pattern A in 58% of baseline pattern B men. Among men who achieved BMIs of <25 kg/m(2) (62% of pattern B men vs. 83% of pattern A men), 81% of pattern B men converted to pattern A. Weight loss was associated with a significantly greater decrease in small, dense LDL subclass 3b in pattern B relative to pattern A men. The lipoprotein profiles of pattern A men who converted from pattern B were comparable to those of men with pattern A at baseline. Conversion of LDL subclass pattern B to pattern A and reversal of ALP can be achieved in a high proportion of overweight men by normalization of adiposity.
Figures

Similar articles
-
Reversal of small, dense LDL subclass phenotype by weight loss is associated with impaired fat oxidation.Obesity (Silver Spring). 2011 Jan;19(1):61-8. doi: 10.1038/oby.2010.142. Epub 2010 Jun 17. Obesity (Silver Spring). 2011. PMID: 20559299 Free PMC article. Clinical Trial.
-
A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins.Am J Clin Nutr. 1999 Mar;69(3):411-8. doi: 10.1093/ajcn/69.3.411. Am J Clin Nutr. 1999. PMID: 10075324 Clinical Trial.
-
Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men.FASEB J. 1994 Jan;8(1):121-6. FASEB J. 1994. PMID: 8299884 Clinical Trial.
-
Atherogenic lipoprotein phenotype and diet-gene interactions.J Nutr. 2001 Feb;131(2):340S-3S. doi: 10.1093/jn/131.2.340S. J Nutr. 2001. PMID: 11160558 Review.
-
Dietary and genetic effects on low-density lipoprotein heterogeneity.Annu Rev Nutr. 2001;21:283-95. doi: 10.1146/annurev.nutr.21.1.283. Annu Rev Nutr. 2001. PMID: 11375438 Review.
Cited by
-
Fructose content of low calorie diets: effect on cardiometabolic risk factors in obese women with polycystic ovarian syndrome: a randomized controlled trial.Endocr Connect. 2015 Sep;4(3):144-54. doi: 10.1530/EC-15-0047. Endocr Connect. 2015. PMID: 26138702 Free PMC article.
-
Energy substrate partitioning and efficiency in individuals with atherogenic lipoprotein phenotype.Obesity (Silver Spring). 2011 Jul;19(7):1360-5. doi: 10.1038/oby.2011.72. Epub 2011 Apr 7. Obesity (Silver Spring). 2011. PMID: 21475144 Free PMC article.
-
Feasibility of Different Exercise Modalities for Community-Dwelling Residents With Physical Inactivity: A Randomized Controlled Trial.J Nurs Res. 2023 Dec 1;31(6):e301. doi: 10.1097/jnr.0000000000000578. J Nurs Res. 2023. PMID: 37883059 Free PMC article. Clinical Trial.
-
Reversal of small, dense LDL subclass phenotype by weight loss is associated with impaired fat oxidation.Obesity (Silver Spring). 2011 Jan;19(1):61-8. doi: 10.1038/oby.2010.142. Epub 2010 Jun 17. Obesity (Silver Spring). 2011. PMID: 20559299 Free PMC article. Clinical Trial.
-
Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.J Clin Endocrinol Metab. 2013 Oct;98(10):3989-98. doi: 10.1210/jc.2013-1452. Epub 2013 Aug 26. J Clin Endocrinol Metab. 2013. PMID: 23979954 Free PMC article. Clinical Trial.
References
-
- Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk Circulation. 1990;82:495–506. - PubMed
-
- Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835–2838. - PubMed
-
- Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104:1108–1113. - PubMed
-
- Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical